416 related articles for article (PubMed ID: 22623680)
21. Conformational properties of prion strains can be transmitted to recombinant prion protein fibrils in real-time quaking-induced conversion.
Sano K; Atarashi R; Ishibashi D; Nakagaki T; Satoh K; Nishida N
J Virol; 2014 Oct; 88(20):11791-801. PubMed ID: 25078700
[TBL] [Abstract][Full Text] [Related]
22. Sialylation Controls Prion Fate
Srivastava S; Katorcha E; Daus ML; Lasch P; Beekes M; Baskakov IV
J Biol Chem; 2017 Feb; 292(6):2359-2368. PubMed ID: 27998976
[TBL] [Abstract][Full Text] [Related]
23. Methionine oxidation interferes with conversion of the prion protein into the fibrillar proteinase K-resistant conformation.
Breydo L; Bocharova OV; Makarava N; Salnikov VV; Anderson M; Baskakov IV
Biochemistry; 2005 Nov; 44(47):15534-43. PubMed ID: 16300402
[TBL] [Abstract][Full Text] [Related]
24. In vitro amplification of scrapie and chronic wasting disease PrP(res) using baculovirus-expressed recombinant PrP as substrate.
Faburay B; Tark D; Kanthasamy AG; Richt JA
Prion; 2014; 8(6):393-403. PubMed ID: 25495764
[TBL] [Abstract][Full Text] [Related]
25. Highly efficient protein misfolding cyclic amplification.
Gonzalez-Montalban N; Makarava N; Ostapchenko VG; Savtchenk R; Alexeeva I; Rohwer RG; Baskakov IV
PLoS Pathog; 2011 Feb; 7(2):e1001277. PubMed ID: 21347353
[TBL] [Abstract][Full Text] [Related]
26. Pathway complexity of prion protein assembly into amyloid.
Baskakov IV; Legname G; Baldwin MA; Prusiner SB; Cohen FE
J Biol Chem; 2002 Jun; 277(24):21140-8. PubMed ID: 11912192
[TBL] [Abstract][Full Text] [Related]
27. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.
Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S
Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027
[TBL] [Abstract][Full Text] [Related]
28. RNA molecules stimulate prion protein conversion.
Deleault NR; Lucassen RW; Supattapone S
Nature; 2003 Oct; 425(6959):717-20. PubMed ID: 14562104
[TBL] [Abstract][Full Text] [Related]
29. Liquid-liquid phase separation of full-length prion protein initiates conformational conversion in vitro.
Tange H; Ishibashi D; Nakagaki T; Taguchi Y; Kamatari YO; Ozawa H; Nishida N
J Biol Chem; 2021; 296():100367. PubMed ID: 33545172
[TBL] [Abstract][Full Text] [Related]
30. Parallel in-register intermolecular β-sheet architectures for prion-seeded prion protein (PrP) amyloids.
Groveman BR; Dolan MA; Taubner LM; Kraus A; Wickner RB; Caughey B
J Biol Chem; 2014 Aug; 289(35):24129-42. PubMed ID: 25028516
[TBL] [Abstract][Full Text] [Related]
31. Liquid-liquid phase separation and fibrillation of the prion protein modulated by a high-affinity DNA aptamer.
Matos CO; Passos YM; do Amaral MJ; Macedo B; Tempone MH; Bezerra OCL; Moraes MO; Almeida MS; Weber G; Missailidis S; Silva JL; Uversky VN; Pinheiro AS; Cordeiro Y
FASEB J; 2020 Jan; 34(1):365-385. PubMed ID: 31914616
[TBL] [Abstract][Full Text] [Related]
32. Crossing the species barrier by PrP(Sc) replication in vitro generates unique infectious prions.
Castilla J; Gonzalez-Romero D; Saá P; Morales R; De Castro J; Soto C
Cell; 2008 Sep; 134(5):757-68. PubMed ID: 18775309
[TBL] [Abstract][Full Text] [Related]
33. Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein.
Piening N; Weber P; Giese A; Kretzschmar H
Biochem Biophys Res Commun; 2005 Jan; 326(2):339-43. PubMed ID: 15582583
[TBL] [Abstract][Full Text] [Related]
34. Shaking alone induces de novo conversion of recombinant prion proteins to β-sheet rich oligomers and fibrils.
Ladner-Keay CL; Griffith BJ; Wishart DS
PLoS One; 2014; 9(6):e98753. PubMed ID: 24892647
[TBL] [Abstract][Full Text] [Related]
35. Synthetic prions and other human neurodegenerative proteinopathies.
Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
[TBL] [Abstract][Full Text] [Related]
36. Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils.
Bocharova OV; Breydo L; Salnikov VV; Baskakov IV
Biochemistry; 2005 May; 44(18):6776-87. PubMed ID: 15865423
[TBL] [Abstract][Full Text] [Related]
37. Spontaneous generation of distinct prion variants with recombinant prion protein from a baculovirus-insect cell expression system.
Imamura M; Tabeta N; Iwamaru Y; Takatsuki H; Mori T; Atarashi R
Biochem Biophys Res Commun; 2022 Jul; 613():67-72. PubMed ID: 35537287
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of infective property of recombinant prion protein amyloids in cultured cells overexpressing cellular prion protein.
Kim DH; Lee HM; Ryou C
J Korean Med Sci; 2014 Dec; 29(12):1604-9. PubMed ID: 25469058
[TBL] [Abstract][Full Text] [Related]
39. Conversion of bacterially expressed recombinant prion protein.
Wang F; Wang X; Ma J
Methods; 2011 Mar; 53(3):208-13. PubMed ID: 21176786
[TBL] [Abstract][Full Text] [Related]
40. Assessment of strain-specific PrP(Sc) elongation rates revealed a transformation of PrP(Sc) properties during protein misfolding cyclic amplification.
Gonzalez-Montalban N; Baskakov IV
PLoS One; 2012; 7(7):e41210. PubMed ID: 22815972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
